Cite
HARVARD Citation
Yamamura, J. et al. (n.d.). 342PResponse to primary treatment for first recurrence independently influences survival of patients with hormone receptor-positive, HER2-negative breast cancer: A multicenter study of 236 recurrent metastatic patients. Annals of oncology. p. . [Online].